End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says | MT |
Apr. 18 | UK Regulator to Consider Undertakings for Theramex-Viatris Deal | MT |
Financials (USD)
Sales 2024 * | 15.22B | Sales 2025 * | 14.98B | Capitalization | 13.49B |
---|---|---|---|---|---|
Net income 2024 * | 1.88B | Net income 2025 * | 989M | EV / Sales 2024 * | 1.76 x |
Net Debt 2024 * | 13.28B | Net Debt 2025 * | 11.4B | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
7.85
x | P/E ratio 2025 * |
13.1
x | Employees | - |
Yield 2024 * |
4.42% | Yield 2025 * |
4.6% | Free-Float | 97.9% |
Latest transcript on Mylan Inc
Managers | Title | Age | Since |
---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 61 | 22-12-28 |
Abhijit Barve
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | - | 20-11-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Melina Higgins
CHM | Chairman | 56 | 20-11-15 |
Mark Parrish
BRD | Director/Board Member | 68 | 20-11-15 |
Harry Korman
BRD | Director/Board Member | 66 | 20-11-15 |
1st Jan change | Capi. | |
---|---|---|
+26.07% | 672B | |
+25.87% | 570B | |
-5.44% | 360B | |
+16.16% | 321B | |
+8.67% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.91% | 149B |